glp 1 and blindness GLP-1 Medications NAION: What Patients Should Know About Sudden Vision Loss Semaglutide May Be Linked to

The medicine is evolving quickly, having already expanded to include oral treatments with the first-ever FDA approval for a GLP-1 pill for weight loss for Wegovy at the end of 2025

Sunscreen: A Scientific Comparison Topical Sunscreen Works only where applied Must be reapplied Doesn't penetrate into melanocyte pathways Can wash/sweat off UVA protection often weak SPF is based only on UVB protection No DNA repair enhancement Useful, but limited

Minimizes fine lines, wrinkles, and signs of aging

In 2026, access is not a secondary consideration in GLP-1 therapy

Research also explores its role in modulating angiogenic and inflammatory pathways under controlled laboratory conditions